Exact Mass: 470.16104500000006
Exact Mass Matches: 470.16104500000006
Found 500 metabolites which its exact mass value is equals to given mass value 470.16104500000006
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
7-hydroxymethotrexate
7-hydroxymethotrexate is a metabolite of methotrexate. Methotrexate, abbreviated MTX and formerly known as amethopterin, is an antimetabolite and antifolate drug. It is used in treatment of cancer, autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions. It acts by inhibiting the metabolism of folic acid. Methotrexate began to replace the more toxic antifolate aminopterin starting in the 1950s. The drug was developed by Yellapragada Subbarao. (Wikipedia) D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists
4-[3-(3,5-dihydroxyphenyl)-5-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol
3-Carboxylic acid-picumast
C25H27ClN2O5 (470.16084020000005)
Docarpamine
Imiglitazar
C28H26N2O5 (470.18416260000004)
Plumieride
C21H26O12 (470.14241960000004)
[2-Oxo-3-(3-oxo-1-phenylbutyl)chromen-4-yl] 2-acetyloxybenzoate
Alvaradoin M
A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.
Alvaradoin L
A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 2-O-senecioyl-alpha-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.
2-(1,3-Benzodioxol-5-yl)-3,5,6,8-tetramethoxy-7-[(3-methyl-2-butenyl)oxy]-4H-1-benzopyran-4-one
didymocalyxin B
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one
((5S,10R,11R,13S)-11,13-bis(4-hydroxyphenyl)-10,11-dihydro-5H-10,5-(epoxymethano)-dibenzo[a,d][7]annulene-1,3,6,8-tetraol)|(-)heimiol A|albiraminol C
1,4,8-trihydroxynaphthalene 1-O-[alpha-L-arabinofuranosyl-(1->6)]-beta-D-glucopyranoside
C21H26O12 (470.14241960000004)
3-{{6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxoprop-2-en-1-yl]-beta-D-glucopyranosyl}oxy}-3-methylglutaric acid|tangshenoside V
C21H26O12 (470.14241960000004)
7-[[6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2H-1-benzopyran-2-one|umbelliferone 7-O-rutinoside
C21H26O12 (470.14241960000004)
4-[(6-O-beta-arabinopyranosyl-beta-glucopyranoside)oxy]-5-methoxycoumarin
C21H26O12 (470.14241960000004)
4beta-hydroxy-6-O-(p-hydroxybenzoyl)-tetrahydrolinaride|americanoside
5-O-feruloyl-3-O-(beta-D-glucopyranosyl)-2-deoxy-D-ribono-gamma-lactone|[(2R,3S)-3-[(beta-D-glucopyranosyl)oxy]-1,2,3,4-tetrahydro-5-oxofuran-2-yl]methyl (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C21H26O12 (470.14241960000004)
(2alpha,3alpha,4beta,5alpha,12R,19alpha)-6,7-didehydro-3,4-dihydroxy-17-methoxy-8-oxo-2,21-cycloaspidospermidine-1,3-dicarboxylic acid dimethyl ester|3-oxo-kopsingine|kopsidarine
5-[4-[2-(3-Hydroxyphenyl)ethyl]phenoxy]-6-methoxy-9,10-dihydrophenanthrene-1,2,7-triol
O-Rutinosylumbelliferone
C21H26O12 (470.14241960000004)
7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-2-one is a natural product found in Morus nigra with data available.
5-[2-(6-Hydroxy-4,7-dimethoxy-benzofuran-5-yl)-2-oxo-ethyl]-4-methoxy-6,6-dimethyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-6-ium
[2,6-dihydroxy-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohex-3-en-1-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
C21H26O12 (470.14241960000004)
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one
7-Hydroxymethotrexat
D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists CONFIDENCE standard compound; INTERNAL_ID 2731 CONFIDENCE standard compound; INTERNAL_ID 8505
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one [IIN-based: Match]
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one_major
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one_68.0\\%
Ala Cys Asp Tyr
C19H26N4O8S (470.14712760000003)
Ala Cys Phe Met
Ala Cys Met Phe
Ala Cys Tyr Asp
C19H26N4O8S (470.14712760000003)
Ala Asp Cys Tyr
C19H26N4O8S (470.14712760000003)
Ala Asp Glu His
Ala Asp His Glu
Ala Asp Tyr Cys
C19H26N4O8S (470.14712760000003)
Ala Glu Asp His
Ala Glu His Asp
Ala Phe Cys Met
Ala Phe Met Cys
Ala His Asp Glu
Ala His Glu Asp
Ala Met Cys Phe
Ala Met Phe Cys
Ala Met Ser Tyr
Ala Met Tyr Ser
Ala Ser Met Tyr
Ala Ser Tyr Met
Ala Tyr Cys Asp
C19H26N4O8S (470.14712760000003)
Ala Tyr Asp Cys
C19H26N4O8S (470.14712760000003)
Ala Tyr Met Ser
Ala Tyr Ser Met
Cys Ala Asp Tyr
C19H26N4O8S (470.14712760000003)
Cys Ala Phe Met
Cys Ala Met Phe
Cys Ala Tyr Asp
C19H26N4O8S (470.14712760000003)
Cys Cys Phe Val
Cys Cys Val Phe
Cys Asp Ala Tyr
C19H26N4O8S (470.14712760000003)
Cys Asp Phe Ser
C19H26N4O8S (470.14712760000003)
Cys Asp His Pro
C18H26N6O7S (470.15836060000004)
Cys Asp Pro His
C18H26N6O7S (470.15836060000004)
Cys Asp Ser Phe
C19H26N4O8S (470.14712760000003)
Cys Asp Tyr Ala
C19H26N4O8S (470.14712760000003)
Cys Glu Gly Tyr
C19H26N4O8S (470.14712760000003)
Cys Glu Tyr Gly
C19H26N4O8S (470.14712760000003)
Cys Phe Ala Met
Cys Phe Cys Val
Cys Phe Asp Ser
C19H26N4O8S (470.14712760000003)
Cys Phe Met Ala
Cys Phe Ser Asp
C19H26N4O8S (470.14712760000003)
Cys Phe Thr Thr
Cys Phe Val Cys
Cys Gly Glu Tyr
C19H26N4O8S (470.14712760000003)
Cys Gly Tyr Glu
C19H26N4O8S (470.14712760000003)
Cys His Asp Pro
C18H26N6O7S (470.15836060000004)
Cys His Pro Asp
C18H26N6O7S (470.15836060000004)
Cys Met Ala Phe
Cys Met Phe Ala
Cys Met Met Ser
Cys Met Ser Met
Cys Pro Asp His
C18H26N6O7S (470.15836060000004)
Cys Pro His Asp
C18H26N6O7S (470.15836060000004)
Cys Ser Asp Phe
C19H26N4O8S (470.14712760000003)
Cys Ser Phe Asp
C19H26N4O8S (470.14712760000003)
Cys Ser Met Met
Cys Ser Val Tyr
Cys Ser Tyr Val
Cys Thr Phe Thr
Cys Thr Thr Phe
Cys Val Cys Phe
Cys Val Phe Cys
Cys Val Ser Tyr
Cys Val Tyr Ser
Cys Tyr Ala Asp
C19H26N4O8S (470.14712760000003)
Cys Tyr Asp Ala
C19H26N4O8S (470.14712760000003)
Cys Tyr Glu Gly
C19H26N4O8S (470.14712760000003)
Cys Tyr Gly Glu
C19H26N4O8S (470.14712760000003)
Cys Tyr Ser Val
Cys Tyr Val Ser
Asp Ala Cys Tyr
C19H26N4O8S (470.14712760000003)
Asp Ala Glu His
Asp Ala His Glu
Asp Ala Tyr Cys
C19H26N4O8S (470.14712760000003)
Asp Cys Ala Tyr
C19H26N4O8S (470.14712760000003)
Asp Cys Phe Ser
C19H26N4O8S (470.14712760000003)
Asp Cys His Pro
C18H26N6O7S (470.15836060000004)
Asp Cys Pro His
C18H26N6O7S (470.15836060000004)
Asp Cys Ser Phe
C19H26N4O8S (470.14712760000003)
Asp Cys Tyr Ala
C19H26N4O8S (470.14712760000003)
Asp Glu Ala His
Asp Glu His Ala
Asp Phe Cys Ser
C19H26N4O8S (470.14712760000003)
Asp Phe Ser Cys
C19H26N4O8S (470.14712760000003)
Asp His Ala Glu
Asp His Cys Pro
C18H26N6O7S (470.15836060000004)
Asp His Glu Ala
Asp His Pro Cys
C18H26N6O7S (470.15836060000004)
Asp Pro Cys His
C18H26N6O7S (470.15836060000004)
Asp Pro His Cys
C18H26N6O7S (470.15836060000004)
Asp Ser Cys Phe
C19H26N4O8S (470.14712760000003)
Asp Ser Phe Cys
C19H26N4O8S (470.14712760000003)
Asp Ser Ser Tyr
C19H26N4O10 (470.16488560000005)
Asp Ser Tyr Ser
C19H26N4O10 (470.16488560000005)
Asp Tyr Ala Cys
C19H26N4O8S (470.14712760000003)
Asp Tyr Cys Ala
C19H26N4O8S (470.14712760000003)
Asp Tyr Ser Ser
C19H26N4O10 (470.16488560000005)
Glu Ala Asp His
Glu Ala His Asp
Glu Cys Gly Tyr
C19H26N4O8S (470.14712760000003)
Glu Cys Tyr Gly
C19H26N4O8S (470.14712760000003)
Glu Asp Ala His
Glu Asp His Ala
Glu Glu Gly His
Glu Glu His Gly
Glu Gly Cys Tyr
C19H26N4O8S (470.14712760000003)
Glu Gly Glu His
Glu Gly His Glu
Glu Gly Tyr Cys
C19H26N4O8S (470.14712760000003)
Glu His Ala Asp
Glu His Asp Ala
Glu His Glu Gly
Glu His Gly Glu
Glu Tyr Cys Gly
C19H26N4O8S (470.14712760000003)
Glu Tyr Gly Cys
C19H26N4O8S (470.14712760000003)
Phe Ala Cys Met
Phe Ala Met Cys
Phe Cys Ala Met
Phe Cys Cys Val
Phe Cys Asp Ser
C19H26N4O8S (470.14712760000003)
Phe Cys Met Ala
Phe Cys Ser Asp
C19H26N4O8S (470.14712760000003)
Phe Cys Thr Thr
Phe Cys Val Cys
Phe Asp Cys Ser
C19H26N4O8S (470.14712760000003)
Phe Asp Ser Cys
C19H26N4O8S (470.14712760000003)
Phe Met Ala Cys
Phe Met Cys Ala
Phe Met Ser Ser
Phe Ser Cys Asp
C19H26N4O8S (470.14712760000003)
Phe Ser Asp Cys
C19H26N4O8S (470.14712760000003)
Phe Ser Met Ser
Phe Ser Ser Met
Phe Thr Cys Thr
Phe Thr Thr Cys
Phe Val Cys Cys
Gly Cys Glu Tyr
C19H26N4O8S (470.14712760000003)
Gly Cys Tyr Glu
C19H26N4O8S (470.14712760000003)
Gly Glu Cys Tyr
C19H26N4O8S (470.14712760000003)
Gly Glu Glu His
Gly Glu His Glu
Gly Glu Tyr Cys
C19H26N4O8S (470.14712760000003)
Gly His Glu Glu
Gly Met Thr Tyr
Gly Met Tyr Thr
Gly Thr Met Tyr
Gly Thr Tyr Met
Gly Tyr Cys Glu
C19H26N4O8S (470.14712760000003)
Gly Tyr Glu Cys
C19H26N4O8S (470.14712760000003)
Gly Tyr Met Thr
Gly Tyr Thr Met
His Ala Asp Glu
His Ala Glu Asp
His Cys Asp Pro
C18H26N6O7S (470.15836060000004)
His Cys Pro Asp
C18H26N6O7S (470.15836060000004)
His Asp Ala Glu
His Asp Cys Pro
C18H26N6O7S (470.15836060000004)
His Asp Glu Ala
His Asp Pro Cys
C18H26N6O7S (470.15836060000004)
His Glu Ala Asp
His Glu Asp Ala
His Glu Glu Gly
His Glu Gly Glu
His Gly Glu Glu
His Asn Asn Ser
His Asn Ser Asn
His Pro Cys Asp
C18H26N6O7S (470.15836060000004)
His Pro Asp Cys
C18H26N6O7S (470.15836060000004)
His Ser Asn Asn
Met Ala Cys Phe
Met Ala Phe Cys
Met Ala Ser Tyr
Met Ala Tyr Ser
Met Cys Ala Phe
Met Cys Phe Ala
Met Cys Met Ser
Met Cys Ser Met
Met Phe Ala Cys
Met Phe Cys Ala
Met Phe Ser Ser
Met Gly Thr Tyr
Met Gly Tyr Thr
Met Met Cys Ser
Met Met Ser Cys
Met Ser Ala Tyr
Met Ser Cys Met
Met Ser Phe Ser
Met Ser Met Cys
Met Ser Ser Phe
Met Ser Tyr Ala
Met Thr Gly Tyr
Met Thr Tyr Gly
Met Tyr Ala Ser
Met Tyr Gly Thr
Met Tyr Ser Ala
Met Tyr Thr Gly
Asn His Asn Ser
Asn His Ser Asn
Asn Asn His Ser
Asn Asn Ser His
Asn Ser His Asn
Asn Ser Asn His
Pro Cys Asp His
C18H26N6O7S (470.15836060000004)
Pro Cys His Asp
C18H26N6O7S (470.15836060000004)
Pro Asp Cys His
C18H26N6O7S (470.15836060000004)
Pro Asp His Cys
C18H26N6O7S (470.15836060000004)
Pro His Cys Asp
C18H26N6O7S (470.15836060000004)
Pro His Asp Cys
C18H26N6O7S (470.15836060000004)
Ser Ala Met Tyr
Ser Ala Tyr Met
Ser Cys Asp Phe
C19H26N4O8S (470.14712760000003)
Ser Cys Phe Asp
C19H26N4O8S (470.14712760000003)
Ser Cys Met Met
Ser Cys Val Tyr
Ser Cys Tyr Val
Ser Asp Cys Phe
C19H26N4O8S (470.14712760000003)
Ser Asp Phe Cys
C19H26N4O8S (470.14712760000003)
Ser Asp Ser Tyr
C19H26N4O10 (470.16488560000005)
Ser Asp Tyr Ser
C19H26N4O10 (470.16488560000005)
Ser Phe Cys Asp
C19H26N4O8S (470.14712760000003)
Ser Phe Asp Cys
C19H26N4O8S (470.14712760000003)
Ser Phe Met Ser
Ser Phe Ser Met
Ser His Asn Asn
Ser Met Ala Tyr
Ser Met Cys Met
Ser Met Phe Ser
Ser Met Met Cys
Ser Met Ser Phe
Ser Met Tyr Ala
Ser Asn His Asn
Ser Asn Asn His
Ser Ser Asp Tyr
C19H26N4O10 (470.16488560000005)
Ser Ser Phe Met
Ser Ser Met Phe
Ser Ser Tyr Asp
C19H26N4O10 (470.16488560000005)
Ser Val Cys Tyr
Ser Val Tyr Cys
Ser Tyr Ala Met
Ser Tyr Cys Val
Ser Tyr Asp Ser
C19H26N4O10 (470.16488560000005)
Ser Tyr Met Ala
Ser Tyr Ser Asp
C19H26N4O10 (470.16488560000005)
Ser Tyr Val Cys
Thr Cys Phe Thr
Thr Cys Thr Phe
Thr Phe Cys Thr
Thr Phe Thr Cys
Thr Gly Met Tyr
Thr Gly Tyr Met
Thr Met Gly Tyr
Thr Met Tyr Gly
Thr Thr Cys Phe
Thr Thr Phe Cys
Thr Tyr Gly Met
Thr Tyr Met Gly
Val Cys Cys Phe
Val Cys Phe Cys
Val Cys Ser Tyr
Val Cys Tyr Ser
Val Phe Cys Cys
Val Ser Cys Tyr
Val Ser Tyr Cys
Val Tyr Cys Ser
Val Tyr Ser Cys
Tyr Ala Cys Asp
C19H26N4O8S (470.14712760000003)
Tyr Ala Asp Cys
C19H26N4O8S (470.14712760000003)
Tyr Ala Met Ser
Tyr Ala Ser Met
Tyr Cys Ala Asp
C19H26N4O8S (470.14712760000003)
Tyr Cys Asp Ala
C19H26N4O8S (470.14712760000003)
Tyr Cys Glu Gly
C19H26N4O8S (470.14712760000003)
Tyr Cys Gly Glu
C19H26N4O8S (470.14712760000003)
Tyr Cys Ser Val
Tyr Cys Val Ser
Tyr Asp Ala Cys
C19H26N4O8S (470.14712760000003)
Tyr Asp Cys Ala
C19H26N4O8S (470.14712760000003)
Tyr Asp Ser Ser
C19H26N4O10 (470.16488560000005)
Tyr Glu Cys Gly
C19H26N4O8S (470.14712760000003)
Tyr Glu Gly Cys
C19H26N4O8S (470.14712760000003)
Tyr Gly Cys Glu
C19H26N4O8S (470.14712760000003)
Tyr Gly Glu Cys
C19H26N4O8S (470.14712760000003)
Tyr Gly Met Thr
Tyr Gly Thr Met
Tyr Met Ala Ser
Tyr Met Gly Thr
Tyr Met Ser Ala
Tyr Met Thr Gly
Tyr Ser Ala Met
Tyr Ser Cys Val
Tyr Ser Asp Ser
C19H26N4O10 (470.16488560000005)
Tyr Ser Met Ala
Tyr Ser Ser Asp
C19H26N4O10 (470.16488560000005)
Tyr Ser Val Cys
Tyr Thr Gly Met
Tyr Thr Met Gly
Tyr Val Cys Ser
Tyr Val Ser Cys
7-Hydroxymethotrexate
D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists
4-(5,7-Dimethoxy-2-oxo-2H-chromen-6-yl)-3-hydroxy-2-methyl-2-butanyl ?-D-glucopyranoside
1-[[2-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide
LK-PENICILLIN IN PENICILLIN G THE DERIVATIVES
C24H26N2O6S (470.15114960000005)
1-N,4-N-bis(3,5-dimethoxyphenyl)-3,6-dimethyl-1,2,4,5-tetrazine-1,4-dicarboxamide
Docarpamine
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
Imiglitazar
C28H26N2O5 (470.18416260000004)
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
7-[2-(1,3-Benzothiazol-2-ylthio)ethyl]-1,3-dimethyl-8-(3-methyl-1-piperidinyl)purine-2,6-dione
N-(2-furanylmethyl)-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
C24H26N2O6S (470.15114960000005)
O-(3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl)-L-serine
A serine derivative that is L-serine having a 3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl moiety attached to the side-chain oxygen.
N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine
C24H27ClN4O4 (470.17207320000006)
(E)-4-[4-(5-methyl-2-phenyl-4-oxazolylmethoxy)benzyloxyimino]-4-phenylbutyric acid
C28H26N2O5 (470.18416260000004)
Alvaradoin K
A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 2-O-senecioyl-alpha-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10R stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.
5-Formimidoyltetrahydrofolate(2-)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
7-{4-[4-(2-fluorophenyl)piperazin-1-yl]-4-oxobutyl}-6-thioxo-6,7-dihydro[1,3]dioxolo[4,5-g]quinazolin-8(5H)-one
5-[2-(6-Hydroxy-4,7-dimethoxy-1-benzofuran-5-yl)-2-oxoethyl]-4-methoxy-6,6-dimethyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-6-ium
3-[2-(tert-butylamino)-2-oxoethoxy]-N-(4-chloro-2,5-dimethoxyphenyl)-2-naphthalenecarboxamide
C25H27ClN2O5 (470.16084020000005)
4-[3-(1,3-Diphenyl-4-pyrazolyl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-4-oxobutanoic acid
C26H22N4O3S (470.14125420000005)
[4-[(2-Chlorophenyl)methyl]-1-piperazinyl]-(6,8-dimethyl-2-pyridin-4-yl-4-quinolinyl)methanone
4-(3,5-dimethyl-1-pyrazolyl)-N-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]benzamide
C23H26N4O5S (470.16238260000006)
N-[3-(1-azepanylsulfonyl)-4-methylphenyl]-2-(4-quinazolinylthio)acetamide
methyl 3-[3-[4-(3-chlorophenyl)piperazin-1-yl]propanoylamino]-4-methoxy-1H-indole-2-carboxylate
C24H27ClN4O4 (470.17207320000006)
(2S)-3-(1H-indol-3-yl)-2-[[2-(4-methyl-6-oxobenzo[c]chromen-3-yl)oxyacetyl]amino]propanoic acid
N-[[(4S,5S)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
O-(3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl)-L-serine
A derivative of L-serine having a 3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl moiety attached to the side-chain oxygen.
(3E,5R)-5-[(1R,5R,6Z,9Z,13R,15R)-5-(acetyloxy)-10-chloro-6-methyl-3-oxo-2,14-dioxabicyclo[11.2.1]hexadeca-6,9-dien-15-yl]-5-hydroxy-3-methylpent-3-enoic acid
N-[[(4S,5S)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
(6R,7R,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7S,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7R,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7S,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6R,7R,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6S,7S,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O5 (470.18416260000004)
N-[[(4R,5S)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5R)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5S)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5R)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5R)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5R)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
(3S)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-hydroxy-3-methylbut-1-ynyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid
C25H30N2O5S (470.18753300000003)
(6S,7S,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7S,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7R,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7S,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7R,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7S,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6R,7R,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6R,7S,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6S,7R,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6S,7R,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6S,7S,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6R,7R,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O5 (470.18416260000004)
(6S,7S,8R)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O5 (470.18416260000004)
D-Galactosyl-3-(N-acetyl-beta-D-galactosaminyl)-L-serine
(2S)-3-(2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-alpha-D-galactopyranosyloxy)-2-azaniumylpropanoate
methyl 2-[(5E)-5-[(3,4-diethoxyphenyl)methylidene]-3-(4-methoxyphenyl)-4-oxo-2-sulfanylideneimidazolidin-1-yl]acetate
C24H26N2O6S (470.15114960000005)
[(2->6)-alpha-D-glucosyl-(1->4)-N-acetyl-alpha-D-neuraminosyl]n
[2,6-dihydroxy-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohex-3-en-1-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
C21H26O12 (470.14241960000004)
5-Formimidoyltetrahydrofolate(2-)
Dianion of 5-formimidoyltetrahydrofolic acid arising from deprotonation of both carboxylic acid functions.
FR177391
A 14-membered macrolide isolated from the Serratia liquefaciens and exhibits anti-hyperlipidemic activity.
O-(3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl)-L-serine zwitterion
Zwitterionic form of O-(3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl)-L-serine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.
O-(3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl)-L-serine zwitterion
An amino acid zwitterion that is the zwitterionic form of O-(3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl)-L-serine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.
AZD1283
C23H26N4O5S (470.16238260000006)
AZD1283 is a potent P2Y12 receptor antagonist with a binding IC50 of 11 nM and a GTPγS IC50 of 25 nM. AZD1283 has excellent antiplatelet aggregation potency. AZD1283 can be used to research thromboembolic disorders[1][2].
SF-22
C28H26N2O3S (470.1664046000001)
SF-22 is a potent and brain-penetrant antagonist of neuropeptide Y receptor (Y2R), with the IC50 value of 750 nM. SF-22 plays an important role in neurological disease[1].
3-(3,5-dihydroxyphenyl)-1-(4-hydroxybenzoyl)-2-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol
methyl (1r,4as,7s,7as)-4'-[(1s)-1-hydroxyethyl]-5'-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-furan]-4-carboxylate
C21H26O12 (470.14241960000004)
17-(3,4-dihydroxyphenyl)-9-(4-hydroxyphenyl)-8-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaene-5,13,15-triol
17-(3,5-dihydroxyphenyl)-9-(4-hydroxyphenyl)-8-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaene-5,13,15-triol
(2e)-1-{2,6-dihydroxy-4,5-dimethoxy-3-[(2e)-3-phenylprop-2-enoyl]-1-benzofuran-7-yl}-3-phenylprop-2-en-1-one
(1r,8s,9r,16r)-8,16-bis(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-2,4,6,10,12,14(17)-hexaene-4,6,9,12-tetrol
6,9-dihydroxy-9-methyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-8,10-dihydro-7h-tetracene-5,12-dione
11,12-dimethyl (1s,12r,15s,20s)-19-formyl-22-oxo-6,8-dioxa-11,19-diazahexacyclo[13.5.3.0¹,¹².0²,¹⁰.0⁵,⁹.0¹⁵,²⁰]tricosa-2(10),3,5(9)-triene-11,12-dicarboxylate
(4s,6r,6as,9r,10s,10as)-6,10-bis(acetyloxy)-6a,9-dihydroxy-3-(methoxymethyl)-6,9-dimethyl-2-oxo-4h,5h,7h,8h,10h-naphtho[4a,4-b]furan-4-yl acetate
(5-oxo-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C21H26O12 (470.14241960000004)
(2s,3r,4s,5s,6r)-2-[(4,8-dihydroxynaphthalen-1-yl)oxy]-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
C21H26O12 (470.14241960000004)
[(2r,3s)-5-oxo-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C21H26O12 (470.14241960000004)
4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol
(1r,8s,9s,16r)-8,16-bis(4-hydroxyphenyl)-17-oxatetracyclo[7.6.2.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10,12,14-hexaene-4,6,12,14-tetrol
(1s,2s,3s,11r,12r,14r,17r,19s,20r,23r)-2,6,6,14,20-pentamethyl-7,16,18,21,24-pentaoxaspiro[heptacyclo[12.8.1.1³,¹⁹.0¹,¹⁹.0²,¹².0⁵,¹⁰.0¹⁷,²³]tetracosane-11,2'-oxirane]-4,9-diene-8,15,22-trione
(1r,2r,3r)-2-(3,5-dihydroxyphenyl)-1-(4-hydroxybenzoyl)-3-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol
(1s,8s,9s,16s)-8,16-bis(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-2,4,6,10(17),11,13-hexaene-4,6,9,12-tetrol
5-[(2s,3r)-2-(3,4-dihydroxyphenyl)-6-hydroxy-4-[(1e)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-3-yl]benzene-1,3-diol
(2s,6r,7r,9r,11s,12r,14s)-11-(acetyloxy)-9-(chloromethyl)-9-hydroxy-14-methyl-5-methylidene-4-oxo-3,13-dioxatetracyclo[8.4.0.0²,⁶.0¹²,¹⁴]tetradecan-7-yl (2e)-4-hydroxy-2-methylbut-2-enoate
C22H27ClO9 (470.1343522000001)